These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 24396140)

  • 1. Host immune status and response to hepatitis E virus infection.
    Krain LJ; Nelson KE; Labrique AB
    Clin Microbiol Rev; 2014 Jan; 27(1):139-65. PubMed ID: 24396140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus: from innate sensing to adaptive immune responses.
    Brüggemann Y; Klöhn M; Wedemeyer H; Steinmann E
    Nat Rev Gastroenterol Hepatol; 2024 Oct; 21(10):710-725. PubMed ID: 39039260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus immunosuppressed animal models.
    Yadav KK; Kenney SP
    BMC Infect Dis; 2024 Sep; 24(1):965. PubMed ID: 39266958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
    Liu P; Du Rj; Wang L; Han J; Liu L; Zhang Yl; Xia Jk; Lu Fm; Zhuang H
    PLoS One; 2014; 9(1):e87600. PubMed ID: 24498149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From discovery to treatment: tracing the path of hepatitis E virus.
    Letafati A; Taghiabadi Z; Roushanzamir M; Memarpour B; Seyedi S; Farahani AV; Norouzi M; Karamian S; Zebardast A; Mehrabinia M; Ardekani OS; Fallah T; Khazry F; Daneshvar SF; Norouzi M
    Virol J; 2024 Aug; 21(1):194. PubMed ID: 39180020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibody response demonstrates inverse correlation with viral load in Bangladeshi women with acute hepatitis E virus genotype 1 infection.
    Sultana R; Islam MT; Bhuyan GS; Sarker SK; Noor FA; Hossain M; Rashid M; Rahmat R; Zaman K; Begum MN; Hassan Z; Karim MM; Qadri F; Mannoor K
    Int J Infect Dis; 2021 Mar; 104():482-490. PubMed ID: 33460834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.
    Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients.
    Nelson KE; Kmush B; Labrique AB
    Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1133-48. PubMed ID: 22114964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy.
    Scotto G; Grisorio B; Filippini P; Ferrara S; Massa S; Bulla F; Martini S; Filippini A; Tartaglia A; Lo Muzio L; Fazio V
    Infect Dis (Lond); 2015; 47(10):707-13. PubMed ID: 25994453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of cellular immune response against Hepatitis E virus (HEV).
    Prabhu SB; Gupta P; Durgapal H; Rath S; Gupta SD; Acharya SK; Panda SK
    J Viral Hepat; 2011 Aug; 18(8):587-94. PubMed ID: 20579277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat.
    Kupke P; Werner JM
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
    Kang S; Myoung J
    J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology and Host Response to HEV.
    Zhou Y
    Adv Exp Med Biol; 2016; 948():113-141. PubMed ID: 27738982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
    Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
    Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model.
    Khateri M; Abdoli A; Motevalli F; Fotouhi F; Bolhassani A; Arashkia A; Jazaeri EO; Shahbazi S; Mehrbod P; Naziri H; Aghasadeghi MR
    IUBMB Life; 2018 Mar; 70(3):207-214. PubMed ID: 29369472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis E virus infection: a paradigm shift?].
    Pischke S; Potthoff A; Hauröder B; Schlué J; Manns MP; Cornberg M; Wedemeyer H
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1129-33. PubMed ID: 20503140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy.
    Donnelly MC; Scobie L; Crossan CL; Dalton H; Hayes PC; Simpson KJ
    Aliment Pharmacol Ther; 2017 Jul; 46(2):126-141. PubMed ID: 28449246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis E vaccines: progress and prospects.
    Worm HC; Wirnsberger G
    Drugs; 2004; 64(14):1517-31. PubMed ID: 15233590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.